Mindset Pharma Inc. - The Investors Coliseum
[adrotate group="1"]

Mindset Pharma Inc.

Mindset Pharma Inc. Logo

Mindset Pharma Inc.

Mindset Pharma Inc. is a drug discovery and development company focused on creating optimized and patentable best-in-class innovative next-generation psychedelic medicines to treat neurological and psychiatric disorders with unmet needs. Mindset was established in order to develop next-generation pharmaceutical assets that leverage the breakthrough therapeutic potential of psychedelic drugs. Mindset is developing several novel families of next-generation psychedelic compounds, as well as an innovative process to chemically synthesize psilocybins in addition to its own proprietary compounds. The company has a co-development agreement with the McQuade Center for Strategic Research and Development, a member of the Otsuka Pharmaceuticals family of companies, covering multiple drug development programs.

Address

217 Queen Street West Suite 401 Toronto, ON M5V 0R2 Canada

Phone

1 +416-479-4094

Website

https://www.mindsetpharma.com

Industry

Biotech/Healthcare

Listings

CNSX-MSET, OTCQB-MSSTF, FSE-9DF

Key Executives

James Lanthier, CEO

 

Leadership Profile

James Lanthier ,CEO

James Lanthier, CEO &- Mindset Pharma Inc.

A seasoned technology executive with strong expertise in corporate finance, public markets and M&A. Most recently, Mr. Lanthier was a co-founder and CEO of Future Fertility, an innovative early stage developer of AI applications for human infertility. As a C-Suite executive, Mr. Lanthier has assisted in the growth and successful exit of numerous technology-enabled businesses through the public markets, including Mood Media, the world’s largest in-store media provider, and Fun Technologies, a pioneer in online casual games.

News and Media

Need More Info From The Company?